This website is intended for US residents.

For Healthcare Providers
Real EKTERLY® (sebetralstat) patient Cari fishing with family Real EKTERLY® (sebetralstat) patient Cari fishing with family

About
EKTERLY

CARI, real EKTERLY patient

EKTERLY is the first and only oral on-demand therapy for hereditary angioedema (HAE)

EKTERLY provides rapid relief from HAE attacks, with a median time of 1.8 hours to beginning of symptom relief.*

Not actual size

  • HAE attack locations

    Effective against all
    types of
    attacks     whether
    you’re on
    preventative
    therapy or not.

  • Timer

    Proven to begin
    providing symptom
    relief fast.

  • Effective against all HAE attacks

    Safety events
    were
    similar to
    placebo.†

*Analysis does not include attacks where response information was not provided. In product label, these attacks were included as having no response to treatment at 12 hours, shifting median to 2.0 hours.

†The most common side effects of EKTERLY include headache.

Where will you go with EKTERLY?

Whether at home or on the go, you can count on EKTERLY when an attack strikes.

Ready for plans
Real EKTERLY® (sebetralstat) patient Cari holding EKTERLY® medication
Ready for plans
Real EKTERLY® (sebetralstat) patient Zach holding EKTERLY® medication
Present with on-demand treatment
Real EKTERLY® (sebetralstat) patient Ellis holding EKTERLY® medication while walking with his mother at football practice
Teaming up for success

See real patient
experiences
with EKTERLY.

Watch patient stories

Talk to your doctor to see
if
EKTERLY is right for you.

Doctor Discussion Guide Download
Hand holding EKTERLY® (sebetralstat) tablets Hand holding EKTERLY® (sebetralstat) tablets
UP NEXT:
Results & Side Effects Right arrow

INDICATION AND IMPORTANT SAFETY INFORMATION

WHAT IS EKTERLY® (sebetralstat)?

EKTERLY is a prescription medicine used to treat sudden (acute) attacks of hereditary angioedema (HAE) in adults and children aged 12 years of age and older. It is not known if EKTERLY is safe and effective in children under 12 years of age.

IMPORTANT SAFETY INFORMATION

Before taking EKTERLY, tell your healthcare provider about all of your medical conditions, including if you:

  • Are pregnant or planning to become pregnant. It is not known if EKTERLY can harm your unborn baby.
  • Are breastfeeding or plan to breastfeed. It is not known if EKTERLY passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby while taking EKTERLY.
  • Have liver problems.

Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking EKTERLY with certain other medicines can cause side effects or affect how well EKTERLY or the other medicines work. Especially tell your healthcare provider if you take any of the following, as their use with EKTERLY is not recommended: itraconazole, phenytoin, efavirenz.

Know the medicines you take. Keep a list of them to show your healthcare provider or pharmacist when you get a new medicine.

What are the possible side effects of EKTERLY?

The most common side effects of EKTERLY include headache. For more information, ask your healthcare provider or pharmacist. Talk to your doctor for medical advice about side effects.

You are encouraged to report side effects related to KalVista products by calling 1-855-258-4782. If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please click here for full Prescribing Information, including Patient Information.